Data Release 34 Highlights: 9 New Studies & 5 Updated Studies

Our collective understanding of the immune system is constantly expanding as more and more high-quality studies are published each day. At ImmPort, we are proud to provide a platform that preserves this data for re-use by the greater scientific community. Recently, 9 new studies were added to ImmPort and 5 existing studies were updated, bringing ImmPort’s total study count to 422. ImmPort now contains high quality immunological-related data for over 58,000 subjects representing over 5 million experimental results. As always, this data is freely available to the scientific community to support current and future research.

With a wealth of data from assay types such as ELISA, RNA sequencing, Q-PCR, and CyTOF, there is much to explore. Additionally, ImmPort’s wide-range of study focus areas, from vaccine and immune response to organ transplantation to autoimmune conditions and many others, provides opportunity for cross-discipline discovery and knowledge sharing.

The following studies were newly added to ImmPort as part of the latest release:

• SDY1369: Immune signatures of responses to infection with Dengue and Zika virus

• SDY1381: Host Determinants Of Protection Against Tuberculosis In Adolescents

• SDY1403: Study of LT recipients investigating proteogenomic signatures of AR, HCV-R and CKD

• SDY1433: Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation

• SDY1536: Unconventional ST2- and CD127-negative lung ILC2 populations

• SDY1555: Allele-specific expression during T cell activation in HLA and other autoimmune loci

• SDY1595: MDR1 expression in hematopoietic cells

• SDY1597: Immune Cell Repertoires in Breast Cancer Patients after Adjuvant Chemotherapy

• SDY1628: Study of Antithymocyte Globulin for Treatment of New-onset T1DM

We encourage all researchers to explore ImmPort, especially in this time of the COVID-19 pandemic. We are stronger together.

For general questions related to ImmPort, please contact immport_helpdesk@immport.org Additionally, ImmPort is listed by NIH as an open domain-specific data repository for upload of COVID-19 research data. Please contact immport_COVID19@immport.org for assistance with COVID-19 related data sharing.